Biotech Business March 1, 1997
"Like ChemTrak's other diagnostic tests, the ColoCARE system is clinically
reliable and user-friendly. Given its price and convenience, responsible adults
should consider self-testing once a year," said Covell.
Who should consider the test? The disease strikes men and women about
equally; those over forty may be increasingly sensitive. Anyone with a personal
or family history of lower intestinal disorders, colorectal cancers, or other
cancers, should take this test yearly or as often as recommended by a doctor.
As reported in USA Today, "An easy take home test for colorectal cancer could
lower the cost and unpleasantness that deter many Americans from being examined
for the nation's leading cancer killer." And, information from the American
Cancer Society makes it clear that early cancer detection is of critical
importance.
ColoCARE has already received FDA clearance to be marketed and will soon be
available in stores and pharmacies across the United States and will retail for
less than $ 7. It will be marketed alongside ChemTrak's other home personal
diagnostic products.
"This test is of great significance and we're exceedingly pleased to bring it
to market at this time," Covell concluded.
Currently, ChemTrak's CholesTrak Home Cholesterol Test, the first
FDA-approved product of its kind, is available internationally and in most
retail pharmacies and mass merchandise outlets in the United States. ChemTrak
has also received FDA marketing clearance for its single-use, whole blood,
physician's office test for Helicobacter Pylori (H. pylori), the bacterium now
recognized as a contributor to duodenal and peptic ulcers in humans. The
company's home HIV test system is pending FDA approval in the United States. |
